The Future of Statistical Methodology in Drug Development

The Future of Statistical Methodology in Drug Development

Author: Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry June 2, 2026 Duration: 31:52
This episode features three leading statistical methodology experts discussing the role, impact, and future of methodology groups in the pharmaceutical industry. They explore organizational structures, skill sets, AI integration, and strategies to accelerate adoption of innovative methods.

Hosted by Alexander Schacht and Benjamin Piske, both practicing biometricians and leaders within the pharmaceutical industry, The Effective Statistician-in association with PSI is a conversation about the practical realities of the profession. This isn't a theoretical lecture series; it's a resource built from the ground up by statisticians who navigate the same challenges you do every day. The discussions focus on actionable strategies for increasing your influence and efficiency, whether you're analyzing data, presenting findings, or guiding a team. You'll hear perspectives on developing leadership qualities even without a formal management title, and gain insight into current debates within the scientific and regulatory communities. The aim is to provide context for the health sector's evolving landscape, translating complex industry dynamics into relevant knowledge for your work. Tune in for a candid exploration of what it means to be a modern statistician, designed to help you refine your approach and achieve a more significant impact. This podcast serves as a professional toolkit, created in association with PSI (Promoting Statistical Insight), for statisticians at any career stage looking to deepen their expertise and navigate their roles with greater confidence and clarity.
Author: Language: English Episodes: 50

The Effective Statistician - in association with PSI
Podcast Episodes
The Evolving Role of Generative AI in Pharma [not-audio_url] [/not-audio_url]

Duration: 33:08
Generative AI is moving fast—and in pharma, it’s no longer just a buzzword. In this episode of The Effective Statistician Podcast, I speak with Manuel Cossio about how Generative AI is already being applied in real-world…
Kicking Off 2026: Gratitude and What’s Ahead [not-audio_url] [/not-audio_url]

Duration: 2:14
As we start 2026, I want to take a moment to express my sincere gratitude to everyone who has been part of The Effective Statistician podcast. This episode features my co-host, Alun Bedding, reflecting on the past year a…
Why to present better and how as a statistician [not-audio_url] [/not-audio_url]

Duration: 36:23
In this episode, I talk with my long-time friend and frequent guest, Kaspar Rufibach, about a skill that quietly determines how much impact we really have: presenting and communicating our work. We walk through how Kaspa…
External control arms - how to get to a good one [not-audio_url] [/not-audio_url]

Duration: 26:51
In this episode, I’m joined by Deepa Jahagirdar, Associate Research Principal at Cytel, to explore what it really takes to build a good external control arm (ECA). Deepa brings a fascinating background from social epidem…
Top 9: Non-parametric analyses - much more than just the Wilcoxon test! [not-audio_url] [/not-audio_url]

Duration: 40:19
Why this episode made our all-time Top 9: If you’ve ever thought “non-parametric = Wilcoxon/Mann-Whitney and that’s it,” this conversation will happily destroy that myth. Frank shows how rank-based methods unlock rigorou…
Introduction to adaptive designs and ICH E20 [not-audio_url] [/not-audio_url]

Duration: 29:36
In this episode, I’m joined once again by my friend and frequent guest, Kaspar Rufibach, to talk about a topic that’s been around for decades but is gaining fresh attention thanks to the new ICH E20 draft guideline—adapt…